Third-party Study Report: Pump Particle Shedding Evaluation
Exhibitor: LEVITRONIX GMBH TAIWAN BRANCH
Date: 2022-06-23
Booth No.: R1101
Pump Particle Shedding Evaluation
Keywords:
- Bioprocessing
- Pump Comparison
- Peristaltic Pump
- 4-Piston Diaphragm Pump
- Particle Shedding
Facts
Peristaltic and 4-piston diaphragm pumps are based on mechanical contact between moving parts such as tube compression or valve interaction. Mechanical contact between moving parts can lead to particle shedding, which leads to product contamination.
Levitronix® pumps have no mechanical contact between moving parts.
Test conditions
The Levitronix® PuraLev® 600SU pump, a 4-Piston Diaphragm Pump, and a peristaltic pump were evaluated for particle shedding. A fixed volume of ultrapure water was recirculated by each pump at a flow rate of 16 l/min and backpressures of 1 and 2.5 bar, respectively. The particle level was measured at selected times and compared.
Results
The peristaltic and 4-Piston Diaphragm pumps generated particle levels 2-3 orders of magnitude greater than the PuraLev® 600SU pump. Regardless of operating conditions, the concentration of particles downstream of the Levitronix® pump was near the detected background-level for the system.
Cumulative particle size distributions at 16 lpm and 2.5 bar
Reference Details: Pump Particle Shedding Evaluation - Levitronix
More Exhibitor's Press Release
- Guard Patch-AIOT wearable system and platform COMMUNICATION AND BIOLOGIC INTEGRATED CIRCUITS (CBIC) LAB, NCKU / 2022-06-25
- AIOT for Prevention of Cardiovascular Disease COMMUNICATION AND BIOLOGIC INTEGRATED CIRCUITS (CBIC) LAB, NCKU / 2022-06-25
- Guard Patch-Your Health Technology Co., Ltd. COMMUNICATION AND BIOLOGIC INTEGRATED CIRCUITS (CBIC) LAB, NCKU / 2022-06-25
- FDA Approves GoldenBiotech IND of Antroquinonol for Relapsed AML GOLDEN BIOTECHNOLOGY CORP. / 2022-06-23
- GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinono GOLDEN BIOTECHNOLOGY CORP. / 2022-06-23
- Third-party Study Report: Investigation of Shear Stress Exerted on CHO Cell by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-06-23
- Third-party Study Report: Investigation of Shear Stress Exerted on Proteins by Different Pump System LEVITRONIX GMBH TAIWAN BRANCH / 2022-06-23
- Twist Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies TWIST BIOSCIENCE / 2022-06-22
- Twist Launches Rapid Turnaround Panels to Advance R&D in MRD Detection in Cancer Screening TWIST BIOSCIENCE / 2022-06-22
- Twist Bioscience Launches High Throughput Antibody Production Platform TWIST BIOSCIENCE / 2022-06-22
- Envirotainer introduces the RAP for the future – part of the Releye® series ENVIROTAINER AB / 2022-06-22
- Lo.Li. Pharma Awards 2022 LO.LI. PHARMA INTERNATIONAL SRL / 2022-06-21
- Lo.Li. Pharma Case History: "The world-famous supplements Made in Italy" LO.LI. PHARMA INTERNATIONAL SRL / 2022-06-21
- 20 Years of Lo.Li. Pharma Group LO.LI. PHARMA INTERNATIONAL SRL / 2022-06-20
- GoldenBiotech is Partnering at BIO-2022, San Diego GOLDEN BIOTECHNOLOGY CORP. / 2022-06-20
- ACRO Biomedical launches the new product iMist Collagen Mist Spray in BIO Asia-Taiwan 2022 ACRO BIOMEDICAL CO., LTD. / 2022-06-15
- TAV VACUUM FURNACES company presentation TAV VACUUM FURNACES SPA / 2022-06-14
- Tanvex BioPharma and TaiMed Biologics form a business alliance to offer efficient CDMO services TAIMED BIOLOGICS INC. / 2022-06-14
- Exosomes and Microvesicles: Concentration, sizing and phenotyping using NTA MALVERN PANALYTICAL / 2022-06-14
- TAIMED JOINS THE 2022 BIO INTERNATIONAL CONVENTION IN SAN DIEGO AND 2022 BIO ASIA TAIWAN IN TAIPEI TAIMED BIOLOGICS INC. / 2022-06-14
